← Back to Search

Cognitive Behavioral Therapy

dCBT for Anxiety

N/A
Waitlist Available
Led By Michael W Otto, PhD
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0 (baseline), week 6, week 10 (post-intervention)
Awards & highlights

Study Summary

This trial is studying a digital therapy to help people with chronic pain and anxiety disorder symptoms. It could help improve care for people with these conditions.

Eligible Conditions
  • Anxiety
  • Chronic Pain
  • Musculoskeletal Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0 (baseline), week 6, week 10 (post-intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0 (baseline), week 6, week 10 (post-intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Anxiety Severity
Anxiety sensitivity
Clinician-rated anxiety severity
+10 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: dCBT ConditionExperimental Treatment1 Intervention
The dCBT used in this study (Daylight) was selected due to its noted efficacy in treating GAD. 25 interventions will be provided in four modules, with an average duration of 20 minutes. Sessions are unlocked weekly, and completion of an initial assessment drives an algorithm to personalize the program. Individuals may progress through treatment at a slower pace than weekly sessions; 10 weeks is allowed for treatment completion. Treatment is based on principles of applied relaxation, stimulus control, cognitive restructuring, and imaginal exposure. Participants schedule a time for each session and receive prompts if they miss the appointment. All interventions are aided by the use of an animated therapist.
Group II: Waitlist (control) ConditionActive Control1 Intervention
Participants allocated to the waitlist (control) condition will not receive an active intervention during the study. Participants will still complete all scheduled study assessments. They will receive access to the dCBT after completion of all study assessments.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
dCBT
2022
N/A
~90

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor
113 Previous Clinical Trials
12,075 Total Patients Enrolled
5 Trials studying Anxiety
451 Patients Enrolled for Anxiety
Michael W Otto, PhDPrincipal InvestigatorBoston University
1 Previous Clinical Trials
180 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Assessment of the Efficacy of Digital CBT for Anxiety in Adults With Chronic Musculoskeletal Pain
Michael Otto 2022. "Assessment of the Efficacy of Digital CBT for Anxiety in Adults With Chronic Musculoskeletal Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04907656.
~27 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top